Fast response power generation from small scale pumped hydro based on reworked quarries:- PROOF OF MARKET through further development and validation of the business trading strategy and revenue forecast model
Fast response power generation from small scale pumped hydro based on reworked quarries:- PROOF OF MARKET through further development and validation of the business trading strategy and revenue forecast model
批准号:
700001
负责人:
金额:
$2.55万
依托单位国家:
英国
项目类别:
GRD Proof of Market
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --
中文摘要
寻求市场赠款的证据,以进行进一步的研究,建模和对英国未来的FR供需进行外部验证,以及拟议的QBC交易策略。FR是保持英国国家电网稳定和国家灯火通明的基本要求。预计未来20年对可再生能源的需求将翻一番,现有设施已经接近满负荷运行。英国《2008年气候变化法》承诺,到2050年,英国将大幅增加风力发电和核能发电。对可再生能源的额外需求是英国能源政策的一个隐藏但不可避免的后果。对于QBC开发的中小型设施生产的FR级电力,应该有一个有保障的和不断扩大的市场。对于QBC来说,为了筹集必要的资金,使确定的地点投入运营,潜在的外部投资者/商业银行/运营伙伴同意收入预测是真实的。这项工作就是为了做到这一点。它将由QBC的总经理Dave Holmes领导,并得到公认的行业专家David Nicols博士的外部支持,而开放大学能源和研究部门的Godfrey Boyle和其他学术机构将承担外部验证。QBC已筹集40万GB的启动股权资金,以推进位于北威尔士的GlynnRhonwy的第一个地点。其他几个网站的土地权谈判也在进行中。赠款资金的重复使用将严重分流满足规划申请的大量成本所需的早期投资资金。通过验证市场概念,这笔赠款资金将使英国PLC获得以下好处:-·增加供应网络的弹性;·在市场FR中带来额外的竞争;以及·为废弃的采石场找到商业用途
英文摘要
A PROOF OF MARKET GRANT is sought to conduct further research, modelling andexternal validation of the future supply and demand for FR in the UK, together with theproposed QBC trading strategy.The Quarry Battery Company (QBC) is at the forefront of developing additional FastResponse (FR) electricity reserve. FR is a fundamental requirement of keeping the UKnational grid stable and the nation's lights on. Demand for FR is forecast to double over thenext 20 years and existing facilities already operate at near full capacity.The UK Climate Change Act 2008 commits the UK to a significant increase in wind andnuclear generation to a 2050 time horizon. Additional demand for FR is a hidden butinevitable consequence of UK energy policy. There should be a guaranteed and expandingmarket for the FR class of electricity to be produced by the small and medium scale facilitiesdeveloped by QBC.For QBC to raise the necessary finance to bring an identified site into operation IT ISIMPERATIVE potential external investors/commercial banks/operating partners ACCEPTTHE REVENUE FORECAST AS BEING REALISTIC.This work is intended to do just that. It will be lead by Dave Holmes the MD of QBC withexternal support from recognised industry expert Dr David Nicols, whilst Godfrey Boyle, ofthe Energy and Research Unit at the Open University, and other academic institutions, willundertake external validation.QBC has raised £400,000 in start up equity funding to take forward the first site at GlynnRhonwy in North Wales. Land rights negotiations are under way on several other sites.Refusal of grant funding would seriously divert early stage investment money that is requiredto meet the substantial cost of the planning application.By validating the market concept, THIS GRANT FUNDING WILL RETURN THEFOLLOWING BENEFITS TO UK PLC:-•add resilience to supply network;•bring additional competition in the market FR; and•find a commercial use for disused quarries
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
-
批准号:82372167
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:江继宏
-
依托单位:
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
-
批准号:82371140
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李姝娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
-
批准号:82371152
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯艳梅
-
依托单位:
PKM2调控CHIP-HSP70-BAG3复合体介导的错误折叠蛋白聚集和清除的分子机制及其在肿瘤靶向治疗中的意义
-
批准号:32000533
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:张臣良
-
依托单位:
内质网相关降解障碍诱导的胰岛Beta细胞功能衰竭机制与干预措施研究
-
批准号:32070762
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:龙乔明
-
依托单位:
长期内质网应激产生原朊病毒蛋白抵抗胰腺癌细胞凋亡的分子机制
-
批准号:32000535
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:高振兴
-
依托单位:
拟南芥辅助共激活因子ADA2b与染色质相关因子ADIP1互作参与DNA损伤响应的机制研究
-
批准号:32000493
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:江洁明
-
依托单位:
生长素响应因子(Auxin Response Factors)在拟南芥雄配子发育中的功能研究
-
批准号:31970520
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:姚小贞
-
依托单位:
组蛋白去乙酰化酶 1 调控线粒体未折叠蛋白反应的分子机制及对衰老相关疾病的应用
-
批准号:31900544
-
项目类别:青年科学基金项目
-
资助金额:15.0万元
-
批准年份:2019
-
负责人:邵丽娃
-
依托单位: